A Multi-Center Open Label Single Arm Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2019
At a glance
- Drugs Carboplatin (Primary) ; Palbociclib (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 28 Dec 2018 Status changed from recruiting to suspended.
- 21 Sep 2017 Status changed from not yet recruiting to recruiting.
- 06 Sep 2017 Planned initiation date changed from 1 Sep 2017 to 1 Nov 2017.